Oral ibuprofen prophylaxis for symptomatic patent ductus arteriosus of prematurity

Journal of the Medical Association of Thailand

Volumn 89, Issue 3, 2006, Pages 314-321

  Sangtawesin, Varaporn ^a   Sangtawesin, Chaisit ^a   Raksasinborisut, Chanchai ^b   Sathirakul, Korbtham ^b   Kanjanapattanakul, Wiboon ^a   Khorana, Meera ^a   Horpaopan, Sunthorn ^a  

^a QUEEN SIRIKIT NATIONAL INSTITUTE OF CHILD HEALTH   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Oral ibuprofen; Patent ductus arteriosus; Preterm

Indexed keywords

IBUPROFEN; PLACEBO;

ABDOMINAL DISTENSION; ABSENCE OF SIDE EFFECTS; ARTICLE; BIRTH WEIGHT; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ECHOCARDIOGRAPHY; FEEDING DISORDER; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; LUNG DYSPLASIA; MALE; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PREVALENCE; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; RETROLENTAL FIBROPLASIA; SEPTICEMIA; SINGLE BLIND PROCEDURE; SUSPENSION; UPPER GASTROINTESTINAL BLEEDING;

CYCLOOXYGENASE INHIBITORS; DUCTUS ARTERIOSUS, PATENT; ECHOCARDIOGRAPHY; FEMALE; HUMANS; IBUPROFEN; INFANT; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; MALE; SINGLE-BLIND METHOD;

EID: 33644988695     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Clyman RI. Ibuprofen and patent ductus arteriosus. N Engl J Med 2000; 343: 728-30.
2. Heymann MA, Rudolph AM, Silverman NH. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N Engl J Med 1976; 295: 530-3.
3. Friedman WF, Hirschklau MJ, Printz MP, Pitlick PT, Kirkpatrick SE. Pharmacological closure of patent ductus arteriosus in preterm infant. N Engl J Med 1976; 295: 526-9.
4. Narayanan M, Cooper B, Weiss H, Clyman RI. Prophylactic indomethacin: factors determining permanent ductus arteriosus closure. J Pediatr 2000; 136: 330-7.
5. Hammerman C, Glaser J, Schimmel MS, Ferber B, Kaplan M, Eidelman AI. Continuous versus multiple rapid infusion of indomethacin: effects on cerebral blood flow velocity. Pediatrics 1995; 95: 244-8.
6. Lee J, Rajadurai VS, Tan KW, Wong KY, Wong EH, Leong JY. Randomized trial of prolonged low-dose versus conventional-dose indomethacin for treating patent ductus arteriosus in very low birth weight infants. Pediatrics 2003; 112: 345-50.
7. Fowlie PW, Davis PG. Prophylactic indomethacin for preterm infants: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 2003; 88: F464-6.
8. Christmann V, Liem KD, Semmekrot BA, van de Bor M. Changes in cerebral, renal and mesenteric blood flow velocity during continuous and bolus infusion of indomethacin. Acta Paediatr 2002; 91: 440-6.
9. Dani C, Bertini G, Reali MF, Murru P, Fabris C, Vangi V, et al. Prophylaxis of patent ductus arteriosus with ibuprofen in preterm infants. Acta Paediatr 2000; 89: 1369-74.
10. Lago P, Bettiol T, Salvadori S, Pitssi I, Vianello A, Chiandetti L, et al. Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial. Eur J Pediatr 2002; 161: 202-7.
11. Van Overmeire B. The use of ibuprofen in neonates in the treatment of patent ductus arteriosus. Int J Clin Pract Suppl 2003; 135: 23-7.
12. Gournay V, Savagner C, Thiriez G, Kuster A, Roze JC. Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants. Lancet 2002; 359: 1486-8.
13. Supapannachart S, Limrungsikul A, Khowsathit P. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital. J Med Assoc Thai 2002; 85(Suppl 4): S1252-8.
14. Chotigeat U, Jirapapa K, Layangkool T. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants. J Med Assoc Thai 2003; 86 (Suppl 3): S563-9.
15. Varvarigou A, Bardin CL, Beharry K, Chemtob S, Papageorgiou A, Aranda JV. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants. JAMA 1996; 275: 539-44.
16. Hariprasad P, Sundarrajan V, Srimathy G, Suthagar B, Ramadevi BS. Oral ibuprofen for closure of hemodynamically significant PDA in premature neonates. Indian Pediatrics 2002; 39: 99-100
17. Heyman E, Morag I, Batash D, Keidar R, Baram S, Berkovitch M. Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: a pilot study. Pediatrics 2003; 112: e354.
18. Patcharaphun S. Prevention of symptomatic patient ductus arteriosus in VLBW infants with oral ibuprofen. A thesis submitted in partial fulfillment of the requirement for the diploma of the Thai Board of Pediatrics of Medical Council; 1999: 1-30.
19. Surawetwongpas P. The efficiency and adverse effects of oral ibuprofen for treatment of PDA in preterm infants. A thesis submitted in partial fulfillment of the requirement for the diploma of the Thai Board of Pediatrics of Medical Council; 2000: 1-14.
20. Tatli MM, Kumral A, Duman N, Demir K, Gurcu O, Ozkan H. Spontaneous intestinal perforation after oral ibuprofen treatment of patent ductus arteriosus in two very-low-birthweight infants. Acta Paediatr 2004; 93: 999-1001.
21. Gournay V, Savagner C, Thiriez G, Kuster A, Roze JC. Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants. Lancet 2002; 359: 1486-8.
22. Cooper-Peel C, Brodersen R, Robertson A. Does ibuprofen affect bilirubin-albumin binding in newborn infant serum? Pharmacol Toxicol 1996; 79: 297-9.
23. Van Overmeire B, Touw D, Schepens PJ, Kearns GL, van den Anker JN. Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus. Clin Pharmacol Ther 2001; 70: 336-43.
24. Sharma PK, Garg SK, Narang A. Pharmacokinetics of oral ibuprofen in premature infants. J Clin Pharmacol 2003; 43: 968-73.
25. Aranda JV, Varvarigou A, Beharry K, Bansal R, Bardin C, Modanlou H, et al. Pharmacokinetics and protein binding of intravenous ibuprofen in the premature newborn infant. Acta Paediatr 1997; 86: 289-93.